Despite improvements achieved in terms of early detection and therapeutic approach, metastatic breast cancer remains one of the principal worldwide causes of death. In recent years, due to the heterogeneous response of each patient to chemotherapy, clinical research highlights the needed of a personalized approach. Circulating tumor cells represent a promising tool for this purpose. Unfortunately, even if their correlation with severity, outcome and metastatic nature of the tumor it has been established, several issues, mainly concerning their characterization and isolation, need to be solved. In this review, latest knowledges on circulating tumor cells and metastatic process in breast cancer were analyzed, aiming to understand their clinic...
Cancer is a prominent cause of death worldwide. In most cases, it is not the primary tumor which cau...
Background: Circulating tumor cells (CTCs) are associated with inferior prognosis in metastatic brea...
Each patient has a unique history of cancer ecosystem development, resulting in intratumor heterogen...
Despite improvements achieved in terms of early detection and therapeutic approach, metastatic breas...
BACKGROUND: The detection of circulating tumor cells (CTCs) predicts overall survival in patients wi...
Abstract Circulating tumor cells (CTCs) are isolated tumor cells disseminated from the site of disea...
Breast cancer (BC) is a disease characterized by high degrees of heterogeneity at mor-phologic, geno...
Background: The detection of circulating tumor cells (CTCs) can predict progression-free (PFS) and o...
Circulating tumor cells (CTCs) are single cells or clusters of cells within the circulatory system o...
Metastases to other organs and the formation of secondary tumors are responsible for 90% of cancer-r...
Cancer metastasis and recurrence are the leading causes of cancer-related death. Tumor cells which l...
Circulating tumor cells (CTCs) are the seeds for cancer metastases development, which is responsible...
Traditional factors currently used for prognostic stratification do not always adequately predict tr...
Cancer is a prominent cause of death worldwide. In most cases, it is not the primary tumor which cau...
Fluid biopsies dependent upon recognition and profiling of circulating tumor cells (CTCs) offer a no...
Cancer is a prominent cause of death worldwide. In most cases, it is not the primary tumor which cau...
Background: Circulating tumor cells (CTCs) are associated with inferior prognosis in metastatic brea...
Each patient has a unique history of cancer ecosystem development, resulting in intratumor heterogen...
Despite improvements achieved in terms of early detection and therapeutic approach, metastatic breas...
BACKGROUND: The detection of circulating tumor cells (CTCs) predicts overall survival in patients wi...
Abstract Circulating tumor cells (CTCs) are isolated tumor cells disseminated from the site of disea...
Breast cancer (BC) is a disease characterized by high degrees of heterogeneity at mor-phologic, geno...
Background: The detection of circulating tumor cells (CTCs) can predict progression-free (PFS) and o...
Circulating tumor cells (CTCs) are single cells or clusters of cells within the circulatory system o...
Metastases to other organs and the formation of secondary tumors are responsible for 90% of cancer-r...
Cancer metastasis and recurrence are the leading causes of cancer-related death. Tumor cells which l...
Circulating tumor cells (CTCs) are the seeds for cancer metastases development, which is responsible...
Traditional factors currently used for prognostic stratification do not always adequately predict tr...
Cancer is a prominent cause of death worldwide. In most cases, it is not the primary tumor which cau...
Fluid biopsies dependent upon recognition and profiling of circulating tumor cells (CTCs) offer a no...
Cancer is a prominent cause of death worldwide. In most cases, it is not the primary tumor which cau...
Background: Circulating tumor cells (CTCs) are associated with inferior prognosis in metastatic brea...
Each patient has a unique history of cancer ecosystem development, resulting in intratumor heterogen...